Assessment of Vertical Pattern in Correlation With Third Molar Inclusion : A 3D CBCT Analysis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15+
SponsorCentral Hospital, Nancy, France

About this trial

The objective is to compare the sagittal and vertical skeletal parameters of patients with an impacted third molar.

Patients will be analyzed according to their skeletal characteristics: skeletal class (sagittal direction) and facial skeletal typology (vertical direction).

The inclusion characteristics of third molars will also be analyzed, to see the links between typology and inclusion. The principal hypothesis is no significant difference in third molar inclusion patterns in relation to skeletal divergence.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

CMV stage 5 on lateral radiography (end of growth)

at least one impacted third molar at minimum Nolla stage 6 development

Disqualifiers

Previous maxillofacial trauma

Growing patients

Missing permanent tooth or early avulsion

Dysplasia

Trial population

French adults with at least one impacted third molar

Trial design

Design model

Other

Time perspective

Retrospective

Treatments tested in this trial

  • Radiographic measurement

    Other intervention

    Measurements taken on 3D radiographs, to assess third molar inclusion and skeletal typology (vertical and sagittal)

Treatment groups

80 Participants
are divided into 3 treatment groups
Group A: Class I1 intervention
Group B: Class II1 intervention
Group C: Class III1 intervention

Trial outcomes

Primary outcomes

1

Distance between the occlusal plane and the second molar

Depth of the third molar in mm

Time frame
One day
2

Angle of the third molar

The coronal-radicular axis of the mandibular third molar, and the occlusal plane of the mandibular 1st and 2nd molars, when these are in a normal, functional position on the arch (in degrees)

Time frame
One day

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.